Alliance for Multispecialty Research was founded in 1994 and became AMR in 2017 with sixteen locations throughout the United States ? fourteen fully-owned research centers and two affiliate centers. Our centers have experience across all phases of research and in a variety of therapeutic areas.
AMR?s performance in vaccine trials has earned the company a reputation of excellence across the industry as well as the Vaccine Industry Excellence (ViE) Award for Best Clinical Trial Site or Network in 2013, 2015 and 2017. AMR has conducted over 600 vaccine studies across a multitude of indications.